Orange : Back on key levels based on weekly price data
Entry price | Target | Stop-loss | Potential |
---|
€9.18 |
€10 |
€8.65 |
+8.89% |
---|
Orange shares are sitting close to an important technical support area around 8.84 EUR based on weekly price data. Against this backdrop, investors can use this good timing for new long positions.
Strengths● The share is getting closer to its long-term support in weekly data, at EUR 8.84, which offers good timing for buyers.
● Its low valuation, with P/E ratio at 9.33 and 8.61 for the ongoing fiscal year and 2021 respectively, makes the stock pretty attractive with regard to earnings multiples.
● This company will be of major interest to investors in search of a high dividend stock.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The company is in debt and has limited leeway for investment
● The technical configuration over the long term remains negative on the weekly chart below the resistance level at 11.01 EUR
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.